Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management
出版年份 2014 全文链接
标题
Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management
作者
关键词
Hematopoietic Stem Cell Transplantation, Candida Species, Invasive Aspergillosis, Caspofungin, Invasive Fungal Infection
出版物
DRUGS
Volume 74, Issue 14, Pages 1573-1585
出版商
Springer Nature
发表日期
2014-09-25
DOI
10.1007/s40265-014-0286-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effectiveness of Primary Anti-Aspergillus Prophylaxis during Remission Induction Chemotherapy of Acute Myeloid Leukemia
- (2014) M. Z. R. Gomes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Positions and Numbers ofFKSMutations in Candida albicans Selectively InfluenceIn VitroandIn VivoSusceptibilities to Echinocandin Treatment
- (2014) M. Lackner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates
- (2014) Gregory A. Eschenauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin
- (2014) Fernando César Bizerra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Initial Use of Echinocandins Does Not Negatively Influence Outcome in Candida parapsilosis Bloodstream Infection: A Propensity Score Analysis
- (2014) Mario Fernández-Ruiz et al. CLINICAL INFECTIOUS DISEASES
- Systemic Antifungal Prophylaxis After Hematopoietic Stem Cell Transplantation: A Meta-Analysis
- (2014) Panayiotis D. Ziakas et al. CLINICAL THERAPEUTICS
- Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 Systemically active antifungal agents when tested against Candida spp.
- (2014) Michael A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methods
- (2014) Ronen Ben-Ami et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
- (2014) Maiken C. Arendrup et al. DRUG RESISTANCE UPDATES
- Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?
- (2014) A. Fekkar et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Candida glabrata Intra-Abdominal Candidiasis Is Characterized by Persistence within the Peritoneal Cavity and Abscesses
- (2014) Shaoji Cheng et al. INFECTION AND IMMUNITY
- Development of echinocandin-resistantCandida albicanscandidemia following brief prophylactic exposure to micafungin therapy
- (2014) M.A. Ruggero et al. Transplant Infectious Disease
- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
- (2013) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of Matrix β-1,3 Glucan in Antifungal Resistance of Non-albicans Candida Biofilms
- (2013) K. F. Mitchell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Species-Specific and Drug-Specific Differences in Susceptibility of Candida Biofilms to Echinocandins: Characterization of Less Common Bloodstream Isolates
- (2013) Maria Simitsopoulou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Frequency offksMutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates
- (2013) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method
- (2013) M. A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization
- (2013) David R. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure
- (2013) James S. Lewis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin
- (2013) A. Fekkar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade
- (2013) A. M. Tortorano et al. INFECTION
- Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Killing rates exerted by caspofungin in 50 % serum and its correlation with in vivo efficacy in a neutropenic murine model against Candida krusei and Candida inconspicua
- (2013) R. Kovacs et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Newer Antifungal Agents for Fungal Infection Prevention During Hematopoietic Cell Transplantation: A Meta-Analysis
- (2013) S.-X. Xu et al. TRANSPLANTATION PROCEEDINGS
- Evolutionary Genomics of Salmonella enterica Subspecies
- (2013) P. T. Desai et al. mBio
- Fks1 and Fks2 Are Functionally Redundant but Differentially Regulated in Candida glabrata: Implications for Echinocandin Resistance
- (2012) Santosh K. Katiyar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Presence of anFKSMutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata
- (2012) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stepwise Development of a Homozygous S80P Substitution in Fks1p, Conferring Echinocandin Resistance in Candida tropicalis
- (2012) Rasmus Hare Jensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DifferentialIn VivoActivities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and withoutFKSResistance Mutations
- (2012) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
- (2012) Michaela Döring et al. BMC INFECTIOUS DISEASES
- Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011
- (2012) A. A. Cleveland et al. CLINICAL INFECTIOUS DISEASES
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
- (2012) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
- (2012) W.W. Hope et al. CLINICAL MICROBIOLOGY AND INFECTION
- Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time–kill methodology
- (2012) Richárd Földi et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Micafungin
- (2012) Lesley J. Scott DRUGS
- In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis
- (2012) E. Spreghini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Epidemiology and echinocandin susceptibility of Candida parapsilosis sensu lato species isolated from bloodstream infections at a Spanish university hospital
- (2012) G. Garcia-Effron et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- CRS-MIS inCandida glabrata: sphingolipids modulate echinocandin-Fks interaction
- (2012) Kelley R. Healey et al. MOLECULAR MICROBIOLOGY
- Hidden Killers: Human Fungal Infections
- (2012) G. D. Brown et al. Science Translational Medicine
- Global Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
- (2012) Sheena D. Singh-Babak et al. PLoS Pathogens
- Candida glabrataMutants Demonstrating Paradoxical Reduced Caspofungin Susceptibility but Increased Micafungin Susceptibility
- (2011) Kelley R. Healey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans
- (2011) Nathan P. Wiederhold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin
- (2011) J. L. Slater et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Fks Hot Spot for Acquired Echinocandin Resistance inSaccharomyces cerevisiaeand Its Contribution to Intrinsic Resistance ofScedosporiumSpecies
- (2011) Michael E. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin ResistanceIn Vivo
- (2011) Keunsook K. Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST technical note on anidulafungin
- (2011) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
- (2011) M.A. Pfaller et al. DRUG RESISTANCE UPDATES
- Current perspectives on echinocandin class drugs
- (2011) David S Perlin Future Microbiology
- Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)
- (2011) Michael A. Pfaller et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy
- (2011) Susan J. Howard et al. JOURNAL OF INFECTIOUS DISEASES
- Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
- (2011) Ronen Ben-Ami et al. JOURNAL OF INFECTIOUS DISEASES
- Importance of Candida–bacterial polymicrobial biofilms in disease
- (2011) Melphine M. Harriott et al. TRENDS IN MICROBIOLOGY
- Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
- (2010) M. Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
- (2010) Olivier Lortholary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
- (2010) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species
- (2010) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)
- (2010) Michael A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Echinocandin Antifungal Drugs in Fungal Infections
- (2010) Sharon C.-A. Chen et al. DRUGS
- Breakthrough Invasive Candidiasis in Patients on Micafungin
- (2010) C. D. Pfeiffer et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species
- (2010) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)
- (2010) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Comparative Efficacy of Echinocandins and Nonechinocandins for the Treatment ofCandida parapsilosisInfections: A Meta-analysis
- (2010) Pramodini B Kale-Pradhan et al. PHARMACOTHERAPY
- The Epidemiology of Candida Colonization and Invasive Candidiasis in a Surgical Intensive Care Unit Where Fluconazole Prophylaxis is Utilized
- (2009) Shelley S. Magill et al. ANNALS OF SURGERY
- Echinocandin Susceptibility Testing of Candida Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media
- (2009) M. C. Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role for Fks1 in the Intrinsic Echinocandin Resistance of Fusarium solani as Evidenced by Hybrid Expression in Saccharomyces cerevisiae
- (2009) S. K. Katiyar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
- (2009) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biofilm Formation and Effect of Caspofungin on Biofilm Structure of Candida Species Bloodstream Isolates
- (2009) J. A. G. Ferreira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit
- (2009) M.A. Ghannoum et al. CLINICAL MICROBIOLOGY AND INFECTION
- Our Current Understanding of Fungal Biofilms
- (2009) Gordon Ramage et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent studies
- (2009) Kieren A Marr CURRENT OPINION IN INFECTIOUS DISEASES
- Antifungal drug resistance: do molecular methods provide a way forward?
- (2009) David S Perlin CURRENT OPINION IN INFECTIOUS DISEASES
- Fungal echinocandin resistance
- (2009) Louise A. Walker et al. FUNGAL GENETICS AND BIOLOGY
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins andCandidaspp.
- (2009) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Candida colonisation as a source for candidaemia
- (2009) L.N. Miranda et al. JOURNAL OF HOSPITAL INFECTION
- Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin
- (2009) Sheena D. Singh et al. PLoS Pathogens
- Reduced Candida glabrata Susceptibility Secondary to an FKS1 Mutation Developed during Candidemia Treatment
- (2008) J. D. Cleary et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin-Resistant Candida tropicalis Strains Causing Breakthrough Fungemia in Patients at High Risk for Hematologic Malignancies
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins
- (2008) M. C. Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pyrosequencing To Detect Mutations in FKS1 That Confer Reduced Echinocandin Susceptibility in Candida albicans
- (2008) N. P. Wiederhold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
- (2008) G. R. Thompson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Functional analysis of Candida albicans GPI-anchored proteins: Roles in cell wall integrity and caspofungin sensitivity
- (2008) Armêl Plaine et al. FUNGAL GENETICS AND BIOLOGY
- Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy
- (2008) N. Kabbara et al. HAEMATOLOGICA
- Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints
- (2008) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mucosal Damage and Neutropenia Are Required for Candida albicans Dissemination
- (2008) Andrew Y. Koh et al. PLoS Pathogens
- Stimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins
- (2008) Louise A. Walker et al. PLoS Pathogens
- Increasing incidence of Candida parapsilosis candidemia with caspofungin usage
- (2007) Graeme N. Forrest et al. JOURNAL OF INFECTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started